![](https://investorshub.advfn.com/uicon/504388.png?cb=1669157843)
Tuesday, June 06, 2023 7:33:34 PM
Granted, this will take years, and for NWBio to successfully achieve several major positive milestones. Most of the NWBO investors here today will probably sell their shares long before the valuation of NWBio reach tens of billions, and especially trillions.
I took a quick look at how much NWBio will be worth, assuming the following:
(1) DCVax-L is approved initially in the US, UK, Canada, Germany and the rest of the EU.
(2) DCVax-L is approved in most of the rest of the world.
(3) DCVax-L is eventually approved as a tissue agnostic treatment for all or most solid tumor cancers. I gradually increased annual global patients each year.
(4) The average revenue per patient for DCVax-L starts out initially at $150,000 per patient. Then because of manufacturing efficiencies due to using Flaskworks devices, and economies of scale due to an increasing number of customers treated each year, the revenue per patient would gradually decrease by about 50%, from $150,000 down to $75,000.
(5) The average multiple of price to sales for a biotech drug company is 5.78. I used this multiple to calculate the total valuation of NWBio for each level of customers treated:
https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html
(6) The value per share is initially based on 1.5 billion shares outstanding. I increased the number of outstanding shares to 1.6 billion shares after the annual number of cancer patients treated exceeded 10,000 patients per year.
Here are the results of these projections below. You can see an eventual valuation of over $1.73 trillion, which equates to $1,083.75 per share, based on 1.6 billion NWBO shares outstanding:
![](http://investorshub.advfn.com/uimage/uploads/2023/6/6/iwyusIMG_1908.jpeg)
![Bullish](/static/images/ih2-bull.png)
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM